Literature DB >> 6443764

The virulence of Pseudomonas aeruginosa.

M Pollack.   

Abstract

Pseudomonas aeruginosa is an opportunistic pathogen whose adaptability, ubiquitousness, and pathogenicity are closely related. Both cell-associated and extracellular products of P. aeruginosa contribute to its virulence. Surface structures, including pili and the polysaccharide capsule or glycocalyx, appear to mediate the initial attachment of P. aeruginosa to its prospective host, thus permitting colonization. Extracellular enzymes such as alkaline protease, elastase, phospholipase C, and exotoxin A degrade infected tissues and promote bacterial invasion. When dissemination occurs, systemic disease results, often with fatal consequences. Although extracellular enzymes of P. aeruginosa figure prominently in local disease processes, exotoxin A and endotoxin are primarily responsible for systemic disease. The most protective antibodies presently known are directed toward the nontoxic portions of P. aeruginosa lipopolysaccharides that serve no known virulence function per se. However, there is preliminary evidence that the protective activity of these opsonic antibodies may be augmented by toxin-neutralizing antibodies directed toward the lipid A moiety of endotoxin and exotoxin A.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6443764     DOI: 10.1093/clinids/6.supplement_3.s617

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  22 in total

1.  Purification of extracellular lipase from Pseudomonas aeruginosa.

Authors:  W Stuer; K E Jaeger; U K Winkler
Journal:  J Bacteriol       Date:  1986-12       Impact factor: 3.490

2.  Production of leukotriene B4 and 5-hydroxyeicosatetraenoic acid by human neutrophils is inhibited by Pseudomonas aeruginosa phenazine derivatives.

Authors:  M Muller; T C Sorrell
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

3.  Functionally active monoclonal antibody that recognizes an epitope on the O side chain of Pseudomonas aeruginosa immunotype-1 lipopolysaccharide.

Authors:  B J Stoll; M Pollack; L S Young; N Koles; R Gascon; G B Pier
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

4.  Neuraminidase 1-mediated desialylation of the mucin 1 ectodomain releases a decoy receptor that protects against Pseudomonas aeruginosa lung infection.

Authors:  Erik P Lillehoj; Wei Guang; Sang W Hyun; Anguo Liu; Nicolas Hegerle; Raphael Simon; Alan S Cross; Hideharu Ishida; Irina G Luzina; Sergei P Atamas; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2018-11-14       Impact factor: 5.157

Review 5.  Pouring salt on a wound: Pseudomonas aeruginosa virulence factors alter Na+ and Cl- flux in the lung.

Authors:  Alicia E Ballok; George A O'Toole
Journal:  J Bacteriol       Date:  2013-07-08       Impact factor: 3.490

6.  Induction of inflammatory mediators (histamine and leukotrienes) from rat peritoneal mast cells and human granulocytes by Pseudomonas aeruginosa strains from burn patients.

Authors:  U Bergmann; J Scheffer; M Köller; W Schönfeld; G Erbs; F E Müller; W König
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

7.  Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model.

Authors:  Andres F Zuluaga; Maria Agudelo; John J Cardeño; Carlos A Rodriguez; Omar Vesga
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

8.  Inhibition of motility of Pseudomonas aeruginosa and Proteus mirabilis by subinhibitory concentrations of azithromycin.

Authors:  G Molinari; P Paglia; G C Schito
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

9.  Pharmacokinetics and safety profile of the human anti-Pseudomonas aeruginosa serotype O11 immunoglobulin M monoclonal antibody KBPA-101 in healthy volunteers.

Authors:  Hedvika Lazar; Michael P Horn; Adrian W Zuercher; Martin A Imboden; Peter Durrer; Michael Seiberling; Rolf Pokorny; Christophe Hammer; Alois B Lang
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

10.  Production of cell-cell signalling molecules by bacteria isolated from human chronic wounds.

Authors:  A H Rickard; K R Colacino; K M Manton; R I Morton; E Pulcini; J Pfeil; D Rhoads; R D Wolcott; G James
Journal:  J Appl Microbiol       Date:  2009-09-21       Impact factor: 3.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.